Blog

Market Overview

In 2023, the patient referral management software market was valued at USD 9,598.3 million. By 2030, it is projected to reach USD 30,221.2 million, growing at a CAGR of 17.9%. This growth is driven by the increasing elderly population, ongoing technological advancements, and government initiatives promoting the adoption of IT solutions in healthcare systems.

Key Benefits and Drivers

The software offers numerous benefits such as precision in activity scheduling, improved access to me

The size of the IoT medical devices market was USD 46.4 billion in 2023, and it will power at a rate of 31% by the end of this decade, reaching USD 297 billion by 2030. This is because of the increasing prevalence of chronic ailments at a global level.

On the basis of product, the vital signs monitoring category had the leading share of 30%, in 2023, and it will power at a rate of 30% by the end of this decade. This is as a result of the increasing occurrence of self-manageable ailments, for exam

In 2023, the worldwide healthcare consulting services market recorded a revenue of USD 31.7 billion. Forecasts predict a robust CAGR of 11.4% from 2024 to 2030, ultimately reaching a projected value of USD 66.6 billion by 2030.

This can be credited to the growing rate of healthcare digitalization, brand positioning, aggressive marketing, and acceptance of new techs in medical sciences. Furthermore, the positive changes in the healthcare IT landscape because of the robust backing by the government

As per a report by P&S Intelligence, the clinical alarm management market generated a value of USD 3,201 million in 2022, and it will touch USD 7,013 million, advancing at a 10.30% CAGR, by 2030.

The growth in the industry is credited to the, increasing healthcare requirement, rising disease incidence, mounting elderly population, and the growing number of government initiatives in developing and developed countries for the adoption of medical alarms.

Moreover, due to the growing investment in IP-

Revenue of USD 1,406.4 million was generated in the global pyrogen test market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.

Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and intr

Dear Global Risk Community member,

Now in 2023 as ESG has transitioned from a value-adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to evolving global regulations and position your life sciences organization for future success. 

I am therefore delighted to announce that the brand-new program for the 2nd Annual ESG in Life Science Summit launching today and this year’s event will be

Pharmaceutical and life sciences companies are in the cross-hairs when it comes to third-party and supply chain risk management. With a huge reliance on third parties across almost every phase of their businesses, a range of general and specific laws and regulations to adhere to, and a surge in cyber-attackson their data assets by malicious players, it’s no wonder that companies struggle to keep up.

COVID-19 has only exacerbated challenges to the industry with business disruption, economic uncert